Current Issue February 2012, Vol. 53, No. 2

The Pan American Society for Clinical Virology (PASCV) was founded in 1977 as the Pan American Group for Rapid Viral Diagnosis (PAG-RVD). It was founded to help raise the standards of diagnostic virology in the Americas as the European Group for Rapid Viral Diagnosis had done elsewhere. The name was changed in 1995 to reflect the expanding role of the society in all areas of clinical virology, including diagnostics, manifestations of viral diseases and viral pathogenesis, prevention of and therapy for viral diseases and the improved understanding of all of these. The PASCV sponsors symposia, workshops and annual awards in clinical virology. Currently 2 awards are presented annually. The Clinical Virology Award (sponsored by Bion Enterprises) and the Diagnostic Virology Award (sponsored by Becton Dickinson). The Society also provides several $600 travel grants, including the Mario Escobar Award, to the Annual Clinical Virology Symposium for students, postdoctoral fellows or technologists who submit abstracts to the meeting.

• HIV-1 mother-to-child transmission and drug resistance among Brazilian pregnant women with high access to diagnosis and prophylactic measures
  10 February 2012

  Keila Correia Alcântara, Janaína Bacelar Accioli Lins, Maly Albuquerque, Letícia Mara Aires, Ludimila Paula Vaz Cardoso, Ana Lúcia Minuzzi, Mariane Martins Araújo Stefani

  • Preview
  • Abstract
  • Full Text
  • PDF (207 KB)

  Abstract: Background: A high-coverage public health prenatal program (70,000 women/year) from central western Brazil/Goias State has represented a unique opportunity for the early diagnosis of HIV-1 a...

• Detection of human rhinovirus C in fecal samples of children with gastroenteritis
  10 February 2012

  Susanna K.P. Lau, Cyril C.Y. Yip, David Christopher Lung, Paul Lee, Tak-Lun Que, Yu-Lung Lau, Kwok-Hung Chan, Patrick C.Y. Woo, Kwok-Yung Yuen

  • Preview
  • Abstract
  • Full Text
  • PDF (685 KB)

  Abstract: Background: Despite recent discovery of the novel human rhinovirus species, HRV-C, little is known about the association of HRV-C in diseases other than respiratory tract infections. Objecti...

• Design and development of a quantitative real time PCR assay for monitoring of HTLV-1 provirus in whole blood
  10 February 2012

  Mahmood Naderi, Mahdi Paryan, Kayhan Azadmanesh, Houshang Rafatpanah, Houri Rezvan, Siamak Mirab Samiee

  • Preview
  • Abstract
  • Full Text
  • PDF (1131 KB)

  Abstract: Background: Proviral load quantification of human T-lymphotropic virus type 1 (HTLV-1) is an essential marker for disease progression. Therefore, accurate and precise quantification of the v...

• Development and evaluation of an assay for HIV-1 protease and reverse transcriptase drug resistance genotyping of all major group-M subtypes
  06 February 2012

  Susan C. Aitken, Aletta Kliphuis, Carole L. Wallis, Mei Ling Chu, Quirine Fillekes, Roos Barth, Wendy Stevens, Tobias F. Rinke de Wit, Rob Schuurman

  • Preview
  • Abstract
  • Full Text
  • PDF (199 KB)

  Abstract: Background: High cost and varying sensitivity for non-B HIV-1 subtypes limits application of current commercial kits for HIV-1 drug resistance genotyping of all major HIV-1 group-M subtypes....

• Detection of ganciclovir resistance mutations by pyrosequencing in HCMV-infected pediatric patients
  03 February 2012

  Fabio Benzi, Irene Vanni, Giulia Cassina, Elisabetta Ugolotti, Eddi Di Marco, Carmela Cirillo, Emilio Cristina, Giuseppe Morreale, Giovanni Melioli, Mauro Malnati, Roberto Biassoni

  • Preview
  • Abstract
  • Full Text
  • PDF (1041 KB)

  Abstract: Background: Human cytomegalovirus (HCMV) is an opportunistic pathogen especially for immuno-suppressed subjects that might develop pharmacological resistance in patients undergoing prolonged...

View More Articles in Press...